HIV/AIDS
Researchers' data from Australia, Spain and the United States advance HIV/AIDS research
Published in AIDS Weekly, July 3rd, 2006
Study 1: A HAART adherence intervention program results in decreases in HIV viral load.
According to recent research from Australia, "The aim was to analyze data from two randomized controlled trials (RCTs) to determine if an adherence intervention program for antiretroviral therapy (ART) resulted in a reduction in viral load.
"A cohort analysis of pre- and postintervention viral loads and CD4 counts using paired analysis was undertaken on participants who received the intervention program. Analysis was also undertaken on a control group."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2006-07-03)
More Articles from AIDS Weekly
- HIV/AIDS Diet & Nutrition
HIV-1-infected patients need higher retinol doses to compensate for urinary loss - HIV/AIDS HAART
HAART susceptibilities determined for HIV-1 non-B subtypes - HIV/AIDS Obstetrics
Protease inhibitor-containing HAART associated with increased risk of preterm delivery - HIV/AIDS Pathogenesis
Cytotoxic T lymphocytes not responsible for majority of infected cell death in HIV/AIDS - HIV/AIDS Therapy
11 Beta-hydroxylase inhibition increases adrenal androgen secretion in HIV-infected women - Adaptive Immune Response
IFN-alpha/beta-dependent cross-priming induced by specific toll-like receptor agonists - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
